Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017 (2017), Article ID 4532409, 15 pages
https://doi.org/10.1155/2017/4532409
Research Article

Increased Abundance of Plasmacytoid Dendritic Cells and Interferon-Alpha Induces Plasma Cell Differentiation in Patients of IgA Nephropathy

1Translational Medical Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
2Department of Nephrology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
3International Travel Health Care Center, Entry-Exit Inspection and Quarantine Bureau, Guangzhou, Guangdong Province, China

Correspondence should be addressed to Nuoyan Zheng; nc.ude.usys.liam@younhz and Xueqing Yu; nc.ude.usys.liam@qxuy

Received 27 May 2017; Revised 30 August 2017; Accepted 24 September 2017; Published 18 December 2017

Academic Editor: Anshu Agrawal

Copyright © 2017 Nuoyan Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Barratt and J. Feehally, “Primary IgA nephropathy: new insights into pathogenesis,” Seminars in Nephrology, vol. 31, no. 4, pp. 349–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Coppo, “The intestine–renal connection in IgA nephropathy,” Nephrology, Dialysis, Transplantation, vol. 30, no. 3, pp. 360–366, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Kiryluk and J. Novak, “The genetics and immunobiology of IgA nephropathy,” The Journal of Clinical Investigation, vol. 124, no. 6, pp. 2325–2332, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. N. Lai, S. C. Tang, F. P. Schena et al., “IgA nephropathy,” Nature Reviews Disease Primers, vol. 2, article 16001, 2016. View at Publisher · View at Google Scholar
  5. A. A. Satoskar, G. Nadasdy, J. A. Plaza et al., “Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 6, pp. 1179–1186, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Rollino, G. Vischini, and R. Coppo, “IgA nephropathy and infections,” Journal of Nephrology, vol. 29, no. 4, pp. 463–468, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Iwama, S. Horikoshi, I. Shirato, and Y. Tomino, “Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury,” American Journal of Kidney Diseases, vol. 32, no. 5, pp. 785–793, 1998. View at Publisher · View at Google Scholar
  8. Y. Kanno, H. Suzuki, H. Okada, Y. Nakazato, and T. Saruta, “Retroviral infection in peripheral mononuclear cells in patients with IgA nephropathy,” Clinical Nephrology, vol. 47, no. 4, pp. 211–216, 1997. View at Google Scholar
  9. S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology, vol. 4, no. 7, pp. 499–511, 2004. View at Publisher · View at Google Scholar
  10. T. Kawai and S. Akira, “Toll-like receptors and their crosstalk with other innate receptors in infection and immunity,” Immunity, vol. 34, no. 5, pp. 637–650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kawai and S. Akira, “The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors,” Nature Immunology, vol. 11, no. 5, pp. 373–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. P. Pulskens, G. J. Teske, L. M. Butter et al., “Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury,” PLoS One, vol. 3, no. 10, article e3596, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ceccarelli, V. Nobili, and A. Alisi, “Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease,” World Journal of Gastroenterology, vol. 20, no. 44, pp. 16443–16451, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. E. D. Papadimitraki, G. K. Bertsias, and D. T. Boumpas, “Toll like receptors and autoimmunity: a critical appraisal,” Journal of Autoimmunity, vol. 29, no. 4, pp. 310–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Colonna, “Toll-like receptors and IFN-α: partners in autoimmunity,” The Journal of Clinical Investigation, vol. 116, no. 9, pp. 2319–2322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Coppo, R. Camilla, A. Amore et al., “Toll-like receptor 4 expression is increased in circulating mononuclear cells of patients with immunoglobulin A nephropathy,” Clinical and Experimental Immunology, vol. 159, no. 1, pp. 73–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. E. Donadio, E. Loiacono, L. Peruzzi et al., “Toll-like receptors, immunoproteasome and regulatory T cells in children with Henoch–Schönlein purpura and primary IgA nephropathy,” Pediatric Nephrology, vol. 29, no. 9, pp. 1545–1551, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Suzuki, Y. Suzuki, I. Narita et al., “Toll-like receptor 9 affects severity of IgA nephropathy,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2384–2395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Kajiyama, Y. Suzuki, M. Kihara, H. Suzuki, S. Horikoshi, and Y. Tomino, “Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy,” Clinical and Developmental Immunology, vol. 2011, Article ID 819646, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Sato, Y. Suzuki, T. Kano et al., “Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients,” Nephrology, Dialysis, Transplantation, vol. 27, no. 3, pp. 1090–1097, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Reizis, A. Bunin, H. S. Ghosh, K. L. Lewis, and V. Sisirak, “Plasmacytoid dendritic cells: recent progress and open questions,” Annual Review of Immunology, vol. 29, no. 1, pp. 163–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Ito, M. Inaba, K. Inaba et al., “A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells,” The Journal of Immunology, vol. 163, pp. 1409–1419, 1999. View at Google Scholar
  23. N. Kohrgruber, N. Halanek, M. Groger et al., “Survival, maturation, and function of CD11c and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines,” The Journal of Immunology, vol. 163, pp. 3250–3259, 1999. View at Google Scholar
  24. J. Olweus, A. Bitmansour, R. Warnke et al., “Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12551–12556, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. M. R. Comeau, A. R. Van der Vuurst de Vries, C. R. Maliszewski, and L. Galibert, “CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion?” The Journal of Immunology, vol. 169, no. 1, pp. 75–83, 2002. View at Publisher · View at Google Scholar
  26. A. Dzionek, Y. Inagaki, K. Okawa et al., “Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions,” Human Immunology, vol. 63, no. 12, pp. 1133–1148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Chehimi, S. E. Starr, H. Kawashima et al., “Dendritic cells and IFN-α-producing cells are two functionally distinct non-B, non-monocytic HLA-DR+ cell subsets in human peripheral blood,” Immunology, vol. 68, no. 4, pp. 486–490, 1989. View at Google Scholar
  28. F. P. Siegal, N. Kadowaki, M. Shodell et al., “The nature of the principal type 1 interferon-producing cells in human blood,” Science, vol. 284, no. 5421, pp. 1835–1837, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. K. B. Elkon and D. M. Santer, “Complement, interferon and lupus,” Current Opinion in Immunology, vol. 24, no. 6, pp. 665–670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Kadowaki, S. Ho, S. Antonenko et al., “Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens,” The Journal of Experimental Medicine, vol. 194, no. 6, pp. 863–870, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. J. Liu, “IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors,” Annual Review of Immunology, vol. 23, no. 1, pp. 275–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Honda, Y. Ohba, H. Yanai et al., “Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction,” Nature, vol. 434, no. 7036, pp. 1035–1040, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Guiducci, G. Ott, J. H. Chan et al., “Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation,” The Journal of Experimental Medicine, vol. 203, no. 8, pp. 1999–2008, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Krug, S. Rothenfusser, V. Hornung et al., “Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells,” European Journal of Immunology, vol. 31, no. 7, pp. 2154–2163, 2001. View at Publisher · View at Google Scholar
  35. A. M. Krieg, “CpG motifs in bacterial DNA and their immune effects,” Annual Review of Immunology, vol. 20, no. 1, pp. 709–760, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Hartmann, J. Battiany, H. Poeck et al., “Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells,” European Journal of Immunology, vol. 33, no. 6, pp. 1633–1641, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Krieg, A. K. Yi, S. Matson et al., “CpG motifs in bacterial DNA trigger direct B-cell activation,” Nature, vol. 374, no. 6522, pp. 546–549, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society Group, D. C. Cattran, R. Coppo et al., “The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification,” Kidney International, vol. 76, no. 5, pp. 534–545, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Kataoka, M. Ohara, K. Shibui et al., “Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters,” Clinical and Experimental Nephrology, vol. 16, no. 5, pp. 706–712, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. H. Kang, S. R. Choi, H. S. Park et al., “The Oxford classification as a predictor of prognosis in patients with IgA nephropathy,” Nephrology, Dialysis, Transplantation, vol. 27, no. 1, pp. 252–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Douagi, C. Gujer, C. Sundling et al., “Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells,” The Journal of Immunology, vol. 182, no. 4, pp. 1991–2001, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. F. He, F. Peng, X. Xia et al., “MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1,” Diabetologia, vol. 57, no. 8, pp. 1726–1736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. K. J. Livak and T. D. Schmittgen, “Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Pietschmann, J. J. Cush, P. E. Lipsky, and N. Oppenheimer-Marks, “Identification of subsets of human T cells capable of enhanced transendothelial migration,” The Journal of Immunology, vol. 149, pp. 1170–1178, 1992. View at Google Scholar
  45. C. M. Sun, E. Deriaud, C. Leclerc, and R. Lo-Man, “Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs,” Immunity, vol. 22, no. 4, pp. 467–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Lande, J. Gregorio, V. Facchinetti et al., “Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide,” Nature, vol. 449, no. 7162, pp. 564–569, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. F. H. Wikstrom, C. Fossum, L. Fuxler, R. Kruse, and T. Lovgren, “Cytokine induction by immunostimulatory DNA in porcine PBMC is impaired by a hairpin forming sequence motif from the genome of Porcine circovirus type 2 (PCV2),” Veterinary Immunology and Immunopathology, vol. 139, no. 2–4, pp. 156–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Ronnblom, G. V. Alm, and M. L. Eloranta, “Type I interferon and lupus,” Current Opinion in Rheumatology, vol. 21, no. 5, pp. 471–477, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. F. O. Nestle, C. Conrad, A. Tun-Kyi et al., “Plasmacytoid predendritic cells initiate psoriasis through interferon-α production,” The Journal of Experimental Medicine, vol. 202, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Gilliet, W. Cao, and Y. J. Liu, “Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases,” Nature Reviews Immunology, vol. 8, no. 8, pp. 594–606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. J. Hooks, H. M. Moutsopoulos, S. A. Geis, N. I. Stahl, J. L. Decker, and A. L. Notkins, “Immune interferon in the circulation of patients with autoimmune disease,” The New England Journal of Medicine, vol. 301, no. 1, pp. 5–8, 1979. View at Publisher · View at Google Scholar
  52. L. Farkas, K. Beiske, F. Lund-Johansen, P. Brandtzaeg, and F. L. Jahnsen, “Plasmacytoid dendritic cells (natural interferon- α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions,” The American Journal of Pathology, vol. 159, no. 1, pp. 237–243, 2001. View at Publisher · View at Google Scholar
  53. T. B. Niewold, J. Hua, T. J. Lehman, J. B. Harley, and M. K. Crow, “High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus,” Genes and Immunity, vol. 8, no. 6, pp. 492–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Bennett, A. K. Palucka, E. Arce et al., “Interferon and granulopoiesis signatures in systemic lupus erythematosus blood,” The Journal of Experimental Medicine, vol. 197, no. 6, pp. 711–723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. E. I. Lichtman, S. M. Helfgott, and M. A. Kriegel, “Emerging therapies for systemic lupus erythematosu—focus on targeting interferon-alpha,” Clinical Immunology, vol. 143, no. 3, pp. 210–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. D. L. Thibault, K. L. Graham, L. Y. Lee, I. Balboni, P. J. Hertzog, and P. J. Utz, “Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus,” Arthritis Research & Therapy, vol. 11, no. 4, article R112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Galicia and J. L. Gommerman, “Plasmacytoid dendritic cells and autoimmune inflammation,” Biological Chemistry, vol. 395, no. 3, pp. 335–346, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Ito, Y. H. Wang, and Y. J. Liu, “Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9,” Springer Seminars in Immunopathology, vol. 26, no. 3, pp. 221–229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Muto, B. Manfroi, H. Suzuki et al., “Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy,” Journal of the American Society of Nephrology, vol. 28, no. 4, pp. 1227–1238, 2016. View at Publisher · View at Google Scholar
  60. P. S. Jahn, K. S. Zanker, J. Schmitz, and A. Dzionek, “BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation,” Cellular Immunology, vol. 265, no. 1, pp. 15–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Gerlini, C. Urso, G. Mariotti et al., “Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes,” Clinical Immunology, vol. 125, no. 2, pp. 184–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Bezalel, K. M. Guri, D. Elbirt, I. Asher, and Z. M. Sthoeger, “Type I interferon signature in systemic lupus erythematosus,” The Israel Medical Association Journal, vol. 16, no. 4, pp. 246–249, 2014. View at Google Scholar
  63. L. Giordani, M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora, “IFN-α amplifies human naïve B cell TLR-9-mediated activation and Ig production,” Journal of Leukocyte Biology, vol. 86, no. 2, pp. 261–271, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Tarlinton, A. Radbruch, F. Hiepe, and T. Dorner, “Plasma cell differentiation and survival,” Current Opinion in Immunology, vol. 20, no. 2, pp. 162–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. I. Vazquez, J. Catalan-Dibene, and A. Zlotnik, “B cells responses and cytokine production are regulated by their immune microenvironment,” Cytokine, vol. 74, no. 2, pp. 318–326, 2015. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Braun, I. Caramalho, and J. Demengeot, “IFN‐α/β enhances BCR‐dependent B cell responses,” International Immunology, vol. 14, no. 4, pp. 411–419, 2002. View at Publisher · View at Google Scholar
  67. C. Gujer, K. J. Sandgren, I. Douagi et al., “IFN-α produced by human plasmacytoid dendritic cells enhances T cell-dependent naïve B cell differentiation,” Journal of Leukocyte Biology, vol. 89, no. 6, pp. 811–821, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. S. J. Harper, A. C. Allen, J. H. Pringle, and J. Feehally, “Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA,” Journal of Clinical Pathology, vol. 49, no. 1, pp. 38–42, 1996. View at Publisher · View at Google Scholar
  69. R. A. Manz, A. Thiel, and A. Radbruch, “Lifetime of plasma cells in the bone marrow,” Nature, vol. 388, no. 6638, pp. 133-134, 1997. View at Publisher · View at Google Scholar · View at Scopus
  70. E. Zhao, H. Xu, L. Wang et al., “Bone marrow and the control of immunity,” Cellular & Molecular Immunology, vol. 9, pp. 11–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. F. Hiepe and A. Radbruch, “Plasma cells as an innovative target in autoimmune disease with renal manifestations,” Nature Reviews Nephrology, vol. 12, no. 4, pp. 232–240, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Dai, H. Wang, S. S. Sung et al., “Interferon alpha on NZM2328.Lc1R27: enhancing autoimmunity and immune complex-mediated glomerulonephritis without end stage renal failure,” Clinical Immunology, vol. 154, no. 1, pp. 66–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Mathian, A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov, “IFN-α induces early lethal lupus in preautoimmune (New Zealand Black × New Zealand White)F1 but not in BALB/c mice,” The Journal of Immunology, vol. 174, no. 5, pp. 2499–2506, 2005. View at Publisher · View at Google Scholar
  74. A. M. Fairhurst, A. Mathian, J. E. Connolly et al., “Systemic IFN-α drives kidney nephritis in B6.Sle123 mice,” European Journal of Immunology, vol. 38, no. 7, pp. 1948–1960, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. G. Jego, A. K. Palucka, J. P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau, “Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6,” Immunity, vol. 19, no. 2, pp. 225–234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Ding, Y. Cai, J. Marroquin, S. T. Ildstad, and J. Yan, “Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner,” The Journal of Immunology, vol. 183, no. 11, pp. 7140–7149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. L. H. Tai, M. L. Goulet, S. Belanger et al., “Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC,” The Journal of Experimental Medicine, vol. 205, no. 13, pp. 3187–3199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Tezuka, Y. Abe, J. Asano et al., “Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction,” Immunity, vol. 34, no. 2, pp. 247–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Jourdan, M. Cren, N. Robert et al., “IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors,” Leukemia, vol. 28, no. 8, pp. 1647–1656, 2014. View at Publisher · View at Google Scholar · View at Scopus
  80. H. Poeck, M. Wagner, J. Battiany et al., “Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help,” Blood, vol. 103, no. 8, pp. 3058–3064, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. Z. Liu and L. Li, “Significance of IgM deposition in IgA nephropathy: an appraisal based on renal re-biopsy,” Zhonghua Yi Xue Za Zhi, vol. 70, no. 6, pp. 324–326, 1990. View at Google Scholar
  82. T. Moriyama, A. Shimizu, T. Takei, K. Uchida, K. Honda, and K. Nitta, “Characteristics of immunoglobulin A nephropathy with mesangial immunoglobulin G and immunoglobulin M deposition,” Nephrology, vol. 15, no. 8, pp. 747–754, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. T. Ootaka, T. Saito, J. Soma, A. Yusa, and K. Abe, “Mechanism of infiltration and activation of glomemlar monocytes/macrophages in IgA nephropathy,” American Journal of Nephrology, vol. 17, no. 2, pp. 137–145, 1997. View at Publisher · View at Google Scholar
  84. Y. Tomino, “Pathogenesis of IgA nephropathy,” Contributions to Nephrology, vol. 157, pp. 1–7, 2007. View at Publisher · View at Google Scholar
  85. T. Ootaka, T. Saito, A. Yusa, T. Munakata, J. Soma, and K. Abe, “Contribution of cellular infiltration to the progression of IgA nephropathy: a longitudinal, immunocytochemical study on repeated renal biopsy specimens,” Nephrology, vol. 1, no. 2, pp. 135–142, 1995. View at Publisher · View at Google Scholar · View at Scopus
  86. W. M. Danilewicz and M. Danilewicz, “Renal interstitial enascin immunostaining and immune cell infiltration in IgA nephropathy,” Nephrology, vol. 6, no. 3, pp. 127–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. G. E. Silva, R. S. Costa, R. C. Ravinal et al., “Renal macrophage infiltration is associated with a poor outcome in IgA nephropathy,” Clinics, vol. 67, no. 7, pp. 697–703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. Z. Shuiai, S. Huijun, G. Weizhong, L. Aimin, and M. Jianhua, “Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: a clinical correlation,” Clinics, vol. 72, no. 2, pp. 95–102, 2017. View at Publisher · View at Google Scholar
  89. D. D. Taub, A. R. Lloyd, K. Conlon et al., “Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells,” The Journal of Experimental Medicine, vol. 177, no. 6, pp. 1809–1814, 1993. View at Publisher · View at Google Scholar
  90. I. F. Charo and R. M. Ransohoff, “The many roles of chemokines and chemokine receptors in inflammation,” The New England Journal of Medicine, vol. 354, no. 6, pp. 610–621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. J. P. Cai, S. Hudson, M. W. Ye, and Y. H. Chin, “The intracellular signaling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium,” Cellular Immunology, vol. 167, no. 2, pp. 269–275, 1996. View at Publisher · View at Google Scholar · View at Scopus
  92. R. Pai, H. Ha, M. A. Kirschenbaum, and V. S. Kamanna, “Role of tumor necrosis factor-α on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction,” Journal of the American Society of Nephrology, vol. 7, no. 6, pp. 914–923, 1996. View at Google Scholar
  93. T. Kusano, H. Takano, D. Kang et al., “Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy,” Human Pathology, vol. 49, pp. 135–144, 2016. View at Publisher · View at Google Scholar · View at Scopus
  94. N. H. Chang, T. T. Li, J. J. Kim et al., “Interferon-α induces altered transitional B cell signaling and function in systemic lupus erythematosus,” Journal of Autoimmunity, vol. 58, pp. 100–110, 2015. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Mathian, M. Gallegos, V. Pascual, J. Banchereau, and S. Koutouzov, “Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice,” European Journal of Immunology, vol. 41, no. 3, pp. 863–872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Liu, R. Bethunaickan, W. Huang et al., “Interferon-α accelerates murine systemic lupus erythematosus in a T cell–dependent manner,” Arthritis and Rheumatism, vol. 63, no. 1, pp. 219–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. K. A. Kirou and E. Gkrouzman, “Anti-interferon alpha treatment in SLE,” Clinical Immunology, vol. 148, no. 3, pp. 303–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Furie, M. Khamashta, J. T. Merrill et al., “Anifrolumab, an anti–interferon-α receptor monoclonal antibody, in moderate-to-severe systemic lupus erythematosus,” Arthritis & Rhematology, vol. 69, no. 2, pp. 376–386, 2017. View at Publisher · View at Google Scholar